Immunome Inc. (IMNM)
undefined
undefined%
At close: undefined
12.45
-1.13%
After-hours Dec 13, 2024, 07:20 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 14.02M - - - - -
Cost of Revenue 22.93M 631.00K 755.00K 755.00K 615.00K 521.00K
Gross Profit -8.91M -631.00K -755.00K -755.00K -615.00K -521.00K
Operating Income -109.53M -36.90M -25.20M -12.26M -10.35M -7.74M
Interest Income 2.72M 5.00K 10.00K 1K 10.00K 39.00K
Pretax Income -106.81M -36.90M -24.71M -17.84M -10.44M -7.84M
Net Income -106.81M -37.51M -24.47M -17.12M -10.55M -7.84M
Selling & General & Admin 19.66M 13.63M 11.09M 4.78M 1.52M 866.00K
Research & Development 103.16M 23.27M 14.11M 7.49M 8.82M 6.88M
Other Expenses - - 503.00K - - -
Operating Expenses 122.82M 36.90M 25.20M 12.26M 10.35M 7.74M
Interest Expense - 5.00K 10.00K 38.00K 106.00K 141.00K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 123.55M 36.90M 25.20M 12.26M 10.35M 7.74M
Income Tax - 617.00K -242.00K -717.00K 106.00K 39.00K
Shares Outstanding (Basic) 19.84M 12.13M 11.54M 10.11M 5.74M 1.09M
Shares Outstanding (Diluted) 19.84M 12.13M 11.54M 10.11M 5.74M 1.09M
EPS (Basic) -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
EPS (Diluted) -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
EBITDA -28.27M -36.27M -23.95M -17.04M -9.72M -7.18M
Depreciation & Amortization 728.00K 631.00K 755.00K 755.00K 615.00K 521.00K